SEC Filing Details

Document Details

Form
Filing Date
Mar 8, 2019
Document Date
Mar 6, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Aeglea Biotherapeutics, Inc.
Issuer
Aeglea BioTherapeutics, Inc.
Filer
Sloan Leslie